Caribou Biosciences Company
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Investors
Funding Status:
Late Stage Venture
Industry:
Biotechnology, Health Care, Therapeutics
Estimated Revenue:
$10M to $50M
Technology:
Others
Number Of Exists:
1
Headquarters:
Berkeley, California, United States
Total Funding:
167549904
Last Funding Date:
2021
Last Funding Type:
Series C
Investor Type:
Late Stage Venture
Employee Number:
101-250
Investors Number:
28
Investment Stage:
N/A
Founded Date:
2011